Roles of the threonine 407, aspartic acid 417, and threonine 419 residues in P450 2B1 in metabolism.
We have previously observed that the quadruple (S407T-N417D-A419T-K473M) and triple (S407T-N17D-A419T) mutants of the chimeric construct of P450 2B1/2B2 do not undergo mechanism-based inactivation by 17alpha-ethynylestradiol (17EE) and tert-butyl 1-methyl-2-propynyl ether (tBMP). The ability of these mutants to metabolize 17EE, benzphetamine, and testosterone has been investigated. The profile for 17EE metabolism by both mutants was characteristic of both wild-types. The two mutants metabolized testosterone to form androstenedione with no formation of the hydroxy products as was seen with both the wild-types. Benzphetamine metabolism by the mutants showed that both mutants exhibited an increased tendency to catalyze demethylation rather than debenzylation. In the presence of the alternate oxidants cumene hydroperoxide and tert-butyl hydroperoxide, the wild-type 2B1 was not inactivated by 17EE. Metabolism of 17EE by 2B1 supported by these alternate oxidants revealed differences in the metabolites that may be related to the inability of 2B1 to be inactivated under these conditions.
Sridar
Chitra
C
Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA.
Harleton
Erin
E
Hollenberg
Paul F
PF
D001224:Aspartic Acid / Q000737:chemistry* / Q000235:genetics; D001589:Benzphetamine / Q000378:metabolism; D019362:Cytochrome P-450 CYP2B1 / Q000737:chemistry* / Q000235:genetics; D004997:Ethinyl Estradiol / Q000378:metabolism; D016877:Oxidants / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism; D013912:Threonine / Q000737:chemistry* / Q000235:genetics
D016877:Oxidants; D001589:Benzphetamine; D013912:Threonine; D001224:Aspartic Acid; D013739:Testosterone; D004997:Ethinyl Estradiol; D019362:Cytochrome P-450 CYP2B1